IPCALAB2019-10-012019-12-31in-bse-fin:OneOperatingExpenses01Member IPCALAB2019-10-012019-12-31in-bse-fin:FourOperatingExpenses01Member IPCALAB2019-10-012019-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member IPCALAB2019-10-012019-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member IPCALAB2019-10-012019-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member IPCALAB2019-10-012019-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member IPCALAB2019-10-012019-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member IPCALAB2019-10-012019-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares IPCALAB 2019-04-01 2020-03-31 2020-01-20 INR Crores Third quarter Single segment Pharmaceuticals 2019-10-01 2019-12-31 Unaudited Standalone 11390700000.00 176300000.00 11567000000.00 3506300000.00 539800000.00 -230800000.00 2177200000.00 38000000.00 461600000.00 2743800000.00 9235900000.00 2331100000.00 0.00 2331100000.00 407800000.00 -43000000.00 364800000.00 0.00 1966300000.00 0.00 0.00 0.00 0.00 1966300000.00 -1900000.00 1964400000.00 0.00 0.00 252700000.00 2 15.56 15.56 0.00 0.00 15.56 15.56 0.00 0.00 0.00 The above financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 12, 2020.The Statutory Auditors have carried out the limited review of the results. n nThe Board has declared an interim dividend of Rs. 5/- per share (250%), for which February 20,2020 has been fixed as the record date for members' entitlement of interim dividend. n nThe Company has only one operating segment viz. 'Pharmaceuticals'. n nFigures of the previous periods have been regrouped wherever necessary. Single segment 2019-04-01 2019-12-31 Unaudited Standalone 33626400000.00 513900000.00 34140300000.00 10600400000.00 1538000000.00 -600800000.00 6429100000.00 123200000.00 1333100000.00 8439300000.00 27862300000.00 6278000000.00 0.00 6278000000.00 1098000000.00 -67000000.00 1031000000.00 0.00 5247000000.00 0.00 0.00 0.00 0.00 5247000000.00 -43400000.00 5203600000.00 0.00 0.00 252700000.00 2 41.53 41.51 0.00 0.00 41.53 41.51 0.00 0.00 0.00 other expenses 2743800000.00 other expenses 8439300000.00